QR код

Effects of denosumab on bone mineral density and bone turnover markers in rheumatoid arthritis patients switching from bisphosphonates

Abstract Background To compare the efficacy of 12-month denosumab treatment on bone mineral density (BMD) and bone turnover markers (BTMs) between treatment-naïve osteoporosis patients with rheumatoid arthritis (RA) and those with previous bisphosphonate (BP) therapy. Methods A total of 36 RA patien...

Повний опис

Збережено в:
Автори: Tetsuya Kaneko, Koichi Okamura, Yukio Yonemoto, Chisa Okura, Takahito Suto, Masahiro Tachibana, Hideo Sakane, Makoto Inoue, Hirotaka Chikuda
Формат: Artigo
Мова:Inglês
Опубліковано: Wiley 2019-10-01
Серія:Journal of Experimental Orthopaedics
Предмети:
Osteoporosis
Denosumab
Bisphosphonate
Rheumatoid arthritis
Fragility fractures
Онлайн доступ:http://link.springer.com/article/10.1186/s40634-019-0211-7
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси